Completed PHASE3 INTERVENTIONAL 2-arm NCT01850303

Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer (MODEL)

Phase III Study Comparing Maintenance With Pemetrexed or Gemcitabine to a Surveillance in Elderly Patients (70 Years Old and More) With a Advanced Non Small Cell Lung Cancer Controlled by Induction Chemotherapy.

Sponsor: Intergroupe Francophone de Cancerologie Thoracique

Conditions Non Small Cell Lung Cancer (Squamous or Non Squamous)

Interventions Gemcitabine Induction chemotherapy Pemetrexed

Updated 12 times since 2017 Last updated: Mar 10, 2023 Started: May 16, 2013 Primary completion: Aug 20, 2018 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01850303, this PHASE3 trial focuses on Non Small Cell Lung Cancer (Squamous or Non Squamous) and remains completed. Sponsored by Intergroupe Francophone de Cancerologie Thoracique, it has been updated 12 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

12 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE3
Sep 2025 — Oct 2025 [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Apr 2023 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 7 earlier versions

Mar 2021 — Apr 2023 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Jan 2021 — Mar 2021 [monthly]

Active Not Recruiting PHASE3
Oct 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE3
Mar 2019 — Oct 2019 [monthly]

Active Not Recruiting PHASE3
Jun 2018 — Mar 2019 [monthly]

Active Not Recruiting PHASE3
Mar 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Mar 2018 [monthly]

Active Not Recruiting PHASE3

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Intergroupe Francophone de Cancerologie Thoracique

Data source: Intergroupe Francophone de Cancerologie Thoracique

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abbeville, France , Aix-en-Provence, France , Amiens, France , Annecy, France , Auxerre, France , Bayonne, France , Besançon, France , Blois, France , Bobigny, France , Bourgoin, France and 55 more locations